WASHINGTON and ATLANTA, Dec. 18,
2018 /PRNewswire/ -- LexisNexis® Risk
Solutions today announced its Risk Defense Platform (RDP) has been certified by SAFE-BioPharma as compliant with the
National Institute of Standards and Technology (NIST) SP 800-63A guidelines at Identity Assurance Level 2 (IAL2). The NIST
guidelines provide technical requirements for federal agencies implementing digital identity services.
SAFE-BioPharma is a U.S. Trust Framework Provider that certifies technologies and practices used by identity credential
issuers. The new certification enables federal agencies to deploy the LexisNexis® Risk Defense Platform suite of identity
proofing solutions with confidence that they meet the highest levels of identity fraud protection. NIST 800-63A certification
means that the LexisNexis Risk Defense Platform can be trusted and used at known levels of assurance by U.S. federal
entities.
"Federal agencies need more robust identity proofing capabilities to combat the constantly-evolving identity theft and fraud
schemes that cost millions of dollars annually," said Haywood
Talcove, CEO, Government,
LexisNexis Risk Solutions. "With NIST 800-63A certification and the release of Gartner's Market Guide for Identity Proofing and Corroboration and the inclusion of the Risk Defense Platform, we
believe LexisNexis Risk Solutions provides the highest level of protection to help ensure that people who interact with and/or do
business with government agencies are securely credentialed and bound to their real-world identities."
The LexisNexis Risk
Defense Platform is a full suite of identity proofing solutions that can be accessed through a single system, giving
government agencies the flexibility to verify identities and self-reported information. It provides a configurable policy
decision engine designed to help government agencies manage complex fraud and identity rules, while reining in the operational
resources needed to defend against fraud.
With NIST 800-63A IAL2 identity assurance level certification, the LexisNexis Risk Defense Platform supports a variety of
acceptable identity proofing techniques to improve user adoption, decrease false negatives and discern between a real user and a
fraudster.
To read Gartner's Market Guide for Identity Proofing and Corroboration, download a complimentary copy at http://solutions.lexisnexis.com\gartnerguide?trmid=gvhhsv18.hhsdemgen.idmrin.lp-162207&source=NISTPR.
For more information about the SAFE-BioPharma/NIST 800-63A certification, visit www.safe-biopharma.org. To learn more about NIST-certified solutions
including the Risk Defense Platform, please visit https://risk.lexisnexis.com/products/risk-defense-platform.
Attribution: Gartner, Market Guide for Identity Proofing and Corroboration, Tricia Phillips,
Jonathan Care, Danny Luong, Ant Allan, 24
April 2018
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise
technology users to select only those vendors with the highest ratings or other designation. Gartner research publications
consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims
all warranties, express or implied, with respect to this research, including any warranties of merchantability or fitness for a
particular purpose.
About LexisNexis® Risk Solutions
LexisNexis Risk Solutions harnesses the power of data and advanced analytics to provide insights that help businesses
and governmental entities reduce risk and improve decisions to benefit people around the globe. We provide data and technology
solutions for a wide range of industries including insurance, financial services, healthcare and government. Headquartered in
metro Atlanta, Georgia, we have offices throughout the world and are part of RELX Group (LSE:REL
/NYSE:RELX ), a global provider of information and analytics for professional and business customers across industries. For more
information, please visit https://risk.lexisnexis.com/ and https://www.relx.com/.
Media Contact
Sara Herrmann
Phone: 202.857.4610
sara.herrmann@lexisnexisrisk.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/lexisnexis-risk-solutions-risk-defense-platform-achieves-nist-800-63a-certification-from-safe-biopharma-300767697.html
SOURCE LexisNexis Risk Solutions